These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 17170039

  • 21. Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies.
    Revicki DA.
    J Clin Psychiatry; 1999; 60 Suppl 1():7-11; discussion 28-30. PubMed ID: 10037164
    [Abstract] [Full Text] [Related]

  • 22. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE.
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [Abstract] [Full Text] [Related]

  • 23. Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance.
    Obenchain RL, Robinson RL, Swindle RW.
    J Biopharm Stat; 2005 Jun; 15(3):419-36. PubMed ID: 15920889
    [Abstract] [Full Text] [Related]

  • 24. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
    Wang H, Zhao H.
    Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
    [Abstract] [Full Text] [Related]

  • 25. A Bayesian analysis of pharmacoeconomic data from a clinical trial on schizophrenia.
    Petit C, Maccario J.
    Stat Med; 2003 Mar 30; 22(6):1025-39. PubMed ID: 12627416
    [Abstract] [Full Text] [Related]

  • 26. Guidelines for performing a pharmacoeconomic analysis.
    Jolicoeur LM, Jones-Grizzle AJ, Boyer JG.
    Am J Hosp Pharm; 1992 Jul 30; 49(7):1741-7. PubMed ID: 1621734
    [Abstract] [Full Text] [Related]

  • 27. Methodological issues in the economic analysis of cancer treatments.
    Tappenden P, Chilcott J, Ward S, Eggington S, Hind D, Hummel S.
    Eur J Cancer; 2006 Nov 30; 42(17):2867-75. PubMed ID: 17023160
    [Abstract] [Full Text] [Related]

  • 28. Bayesian cost-effectiveness analysis from clinical trial data.
    O'Hagan A, Stevens JW, Montmartin J.
    Stat Med; 2001 Mar 15; 20(5):733-53. PubMed ID: 11241573
    [Abstract] [Full Text] [Related]

  • 29. Pharmacoeconomics.
    Ahuja J, Gupta M, Gupta AK, Kohli K.
    Natl Med J India; 2004 Mar 15; 17(2):80-3. PubMed ID: 15141600
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC, Russo DP.
    J Am Osteopath Assoc; 2006 Aug 15; 106(8):457-63. PubMed ID: 16943515
    [Abstract] [Full Text] [Related]

  • 34. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.
    Willan AR, Briggs AH, Hoch JS.
    Health Econ; 2004 May 15; 13(5):461-75. PubMed ID: 15127426
    [Abstract] [Full Text] [Related]

  • 35. Understanding health economic analysis in critical care: insights from recent randomized controlled trials.
    Sud S, Cuthbertson BH.
    Curr Opin Crit Care; 2011 Oct 15; 17(5):504-9. PubMed ID: 21900769
    [Abstract] [Full Text] [Related]

  • 36. [Therapy of arterial hypertension: benefits, costs, challenges].
    Zanchetti A.
    Ann Ital Med Int; 1996 Oct 15; 11 Suppl 2():75S-81S. PubMed ID: 9004827
    [Abstract] [Full Text] [Related]

  • 37. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
    Uyl-de Groot CA.
    Eur J Cancer; 2006 Nov 15; 42(17):2862-6. PubMed ID: 17008095
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prostate Cancer Intervention Versus Observation Trial: economic analysis in study design and conditions of uncertainty.
    Schwartz JS.
    J Natl Cancer Inst Monogr; 1995 Nov 15; (19):73-5. PubMed ID: 7577211
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.